Frontlight ResearchEarly access
Trial site
St. Luke's University Health Network
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Acute myeloid leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 12 trials
- Phase 32 trials
- Status
- Completed2 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Angiodynamics, Inc.1 trial
- Regeneron Pharmaceuticals1 trial
- Rina Plattner1 trial
- Takeda1 trial
- Ultimovacs ASA1 trial
Running trials
Recruiting
Recruiting
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
Active, not recruiting
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026